Clinical Trial Alert

Blog Post

Clinical Trial Alert: Phase 3 Study of Tofersen in Presymptomatic Adults with SOD1 mutation

By Sujatha Gurunathan | August 22, 2023
Blog Post

Clinical Trial Alert: Phase 2 Study of Oral Ifetroban in Individuals with DMD

By Sujatha Gurunathan | August 9, 2023
Clinical Trial Alert with image of researcher's gloved hand holding a test tube
Blog Post

Clinical Trial: Phase 1/2 Study of BIIB105 in Individuals with ALS

By Sujatha Gurunathan | May 8, 2023
Green background with word Clinical Trial Alert and a picture of scientists in a lab
Blog Post

Clinical Trial Alert: Phase 3 Study of Pozelimab and Cemdisiran in Adults with gMG

By Sujatha Gurunathan | April 26, 2023
Green background with word Clinical Trial Alert and a picture of scientists in a lab
Blog Post

Clinical Trial Alert: Phase 3 Study of Taldefgrobep Alfa in Children/Adults Ages 4-21with SMA

By Sujatha Gurunathan | April 10, 2023
Clinical Trial Alert with image of researcher's gloved hand holding a test tube
Blog Post

Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults with Generalized Myasthenia Gravis (gMG)

By Sujatha Gurunathan | March 9, 2023
Blog Post

Clinical Trial Alert: Phase 2 Study of EDG-5506 in Adults or Adolescents with BMD

By Sujatha Gurunathan | February 1, 2023
Clinical Trial Alert with image of researcher's gloved hand holding a test tube
Blog Post

Clinical Trial Alert: Medical Device Feasibility Study for People with Paralysis

By Sujatha Gurunathan | December 14, 2022
Clinical Trial Alert with image of medical researcher looking at computer screen
Blog Post

Clinical Trial Alert: Phase 2 Study of a New Tool for Muscle Assessment in People with Neuromuscular Disease

By Sujatha Gurunathan | December 14, 2022
Blog Post

Clinical Trial Alert: Phase 2 Study of Vamorolone in Adults with BMD

By Sujatha Gurunathan | November 7, 2022